- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 447
MedImmune Ventures bumps up funds by $100m
Biopharma company AstraZeneca has increased the capital in its corporate venturing fund to $400m, as it invests in life sciences company NeuProtect.
Nov 30, 2011Mitsui, ADM team with New Hope
The agribusiness firm is reportedly teaming up with Mitsui and Archer Daniels Midland to establish a corporate venturing fund that will operate outside of China.
Nov 28, 2011Maybank launches $500m cleantech fund
The Malaysian financial services firm is launching the private equity fund in conjunction with investment units connected to the World Bank and US government, and will prioritise power generation infrastructure.
Nov 27, 2011Intel Ultrabook fund to invest $100m a year
Intel Capital has detailed its plans for its $300m Ultrabook fund, which a senior Intel executive said was a "top priority" for the corporate venturing unit.
Nov 17, 2011Intel to fund AppUp makers with $100m
Intel's corporate venturing unit follows up its launch of a $300m Ultrabook fund with a software-based corporate venturing push to create a stronger position in portable devices.
Nov 16, 2011WuXi PharmaTech experiments with fund
The biopharmaceutical company has launched a $50m technology and life sciences corporate venturing unit, according to its latest financial results.
Nov 15, 2011About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


